Karkkainen and colleagues created a realistic 3D printed AAA model for simulation of endovascular aneurysm repair by surgical trainees with different experiences
[48][76]. Their 3D printed AAA model consists of three layers: inner rigid layer and soft flexible outer layer with each having 3 mm thickness and the thin 1 mm inside layer covering the rigid one. The model was connected to a fluid pump with endovascular stent grafting procedures performed under angiography. Twenty trainees (13 were less experienced and seven were experienced) participated in performing 22 simulations with experienced trainees having significantly lower procedural time and fluoroscopic exposure time than inexperienced ones (
p < 0.05). All experienced trainees completed the procedures independently and in less than 45 min, in contrast, only two of the less experienced trainees completed the entire procedures independently and six out of 13 completed the procedures in less than 45 min. This study presents another opportunity of using 3D printed aorta models for simulation and training of surgical procedures
[48][76].
3D printing models of aortic dissection, in particular, reproducing the intimal flap is very challenging due to the very thin structure separating true lumen from false lumen
[36][37][64,65]. Limited research is done in this area and a study by Hossien et al. reported interesting findings
[39][67]. Three cases of type A dissection were selected with involvement of aortic branches to some extent. 3D aortic models were printed using polylactic acid materials demonstrating true and false lumen in relation to the aortic branches. Intimal flap was also printed to separate true lumen from the false lumen in their case report. Similar to other aortic disease, the 3D printed models allow for surgical simulation of complex endovascular repair of aortic dissection, although further research is needed to test its clinical value in more cases.
Tong et al. expanded the application of 3D printing aorta models to guide surgical planning of fenestration for treatment of patients with thoracoabdominal aortic aneurysm (TAAA)
[49][77]. Their retrospective study comprised 34 patients who received fenestrated endovascular stent graft repair (fEVAR) for thoracoabdominal aortic disease (19 had aortic dissection and 15 had thoracic abdominal aortic aneurysms). CT angiographic images were used to create patient-specific models which were printed using materials for biocompatibility and transparency. The aortic stent graft was deployed in each 3D printed model in the operating room to determine the exact position of each fenestration or branch which was marked on the stent graft. This allows for accurate planning of personalised fEVAR based on measurements of the size of the fenestrations for individual arterial branches, thus reducing the risk of complications such as endoleak. Following customization, the fenestrated stent graft was reloaded into the delivery sheath for patient development. Results showed the successful treatment of these complicated thoracoabdominal aortic disease by customized fenestrated stent grafts with a mean follow-up of 8.5 months in this case series. All of the bridged visceral vessels were patent with no enlargement of the aneurysm during the follow-up
[49][77]. This study proves the clinical value of 3D printed aortic models in guiding treatment of aortic disease by fEVAR, although further research on a large sample size with long follow-up of clinical outcomes is warranted.
5. 3D Printing in Pulmonary Artery Disease
Application of 3D printing in pulmonary diseases mainly lies in the pre-surgical planning for treatment of congenital heart disease involving anomalies such as pulmonary atresia or stenosis or coronary-pulmonary artery fistula
[50][51][52][53][78,79,80,81]. With patient-specific 3D printed models incorporated into the management plan, it was found useful to assist decision making and reduce the contrast volume during angiography and improve the performance efficiency by interventional cardiologists.
An emerging area is to use 3D printing for detection of pulmonary embolism aiming to develop optimal CT pulmonary angiography (CTPA) protocols
[54][55][56][82,83,84]. A 3D printed pulmonary artery model using normal CTPA images was generated comprising the main pulmonary arteries
[54][82]. The model was scanned on a 64-slice CT scanner with different protocols. There was high accuracy between the 3D printed model and original CT images with respect to replication of normal anatomy with mean difference between original CT images, STL and 3D printed model less than 5%. Low-dose CTPA protocol such as use of 80 kilovoltage peak (kVp) with 0.9 pitch was recommended with resultant lower radiation dose while still acquiring diagnostic images. This preliminary finding was supported by later experiments with simulation of pulmonary embolism in the 3D printed model.
With successful creation of personalized pulmonary artery model, researchers further tested different CTPA protocols using the 2nd and 3rd generation dual-source CT scanners. Large and small emboli were inserted into the main and side pulmonary arteries to mimic pulmonary embolism
[55][56][83,84]. A series of CT scans were performed with kVp ranging from 70 to 80, 100 and 120, pitch 0.9, 2.2 and 3.2. Image quality was quantitatively analysed by measuring the signal-to-noise ratio and qualitatively assessed by two experienced radiologists. Results showed the feasibility of developing low-dose CTPA protocols when kVp was reduced from 120 to 100 or 80 and pitch was increased to 2.2 or 3.2 without significantly affecting the image quality when 128-slice CT was used
[55][83]. Whereas when CTPA was conducted on the latest CT such as 192-slice scanner, ultra low-dose protocol was also achievable when further reducing kVp to 70 and increasing pitch to 2.2 or 3.2 still allowing for detection of small and peripheral pulmonary embolism with no significant effect on the image quality
[56][84].
These findings indicate the potential applications of 3D printed models in optimizing CT scanning protocols, in particular in the diagnostic detection of pulmonary embolism, given the fact that CTPA is the first line technique in the diagnosis of pulmonary embolism. 3D printed realistic models offer advantages over commercial body phantoms not only because of low cost, but also the capability of providing individualized anatomy and pathology associated with 3D printed models as opposed to the commercial ones with only showing average adult or paediatric anatomical structures. Further research should focus on developing 3D printed chest phantom with simulation of bones, lungs, heart and cardiovascular vessels as well as muscles to represent realistic anatomical environment, thus protocols including chest and cardiac CT imaging could be optimized.
Another novel application of 3D printing technique is to assist management with the recent coronavirus disease 2019 (COVID-19) pandemic which results in a shortage of medical supplies, in particular, the personal protective equipment (PPE)
[57][58][59][60][85,86,87,88], given the primary presentation of respiratory symptoms by COVID-19
[61][62][63][64][65][89,90,91,92,93], although it is also associated with cardiovascular disease
[66][67][68][69][94,95,96,97]. 3D printing is playing an important role in providing medical devices including PPE when still fighting against the COVID-19 as shown in some reports documenting an overview of 3D printing applications and challenges in the COVID-19
[59][70][87,98].
6. 3D Bioprinting in Cardiovascular Disease
Bioprinting is promising, although it is still in its early stage. Tissue engineering combined with 3D printing represents a fast developing technique in recent years with creation of scaffold structures for use in regeneration of tissues and organs
[71][72][73][74][75][76][77][78][99,100,101,102,103,104,105,106]. In recent years, significant progress has been made in 3D bioprinting with studies reporting promising results of printing cardiovascular tissues and organs.
Biomaterials guarantee the success of 3D bioprinting as materials must be biocompatible and non-toxic. Further, mechanical properties are equally important as they influence cell function and viability and cardiovascular structural integrity
[79][80][81][107,108,109]. Bioinks used for bioprinting of cardiovascular tissues also need to mimic properties such as stiffness of the extracellular matrix of heart and other tissues
[82][110].
Progress in 3D bioprinting and tissue engineering has made possible to generate 3D printed cardiovascular constructs, however, to achieve physiological levels of cardiomyocytes is still challenging with many obstacles to be overcome before printing tissues with the clinical sizes. Cell-laden bioprinting represents a very promising technology since it is capable of achieving well-controlled distribution of the cells (both cell density and diffusion distance) in a complex environment, mimicking the function of cardiovascular tissue and cardiomyocytes. Several studies have reported the feasibility of 3D bioprinting cardiovascular constructs, although the research was based on a small scale of vascular channels
[83][84][85][86][87][88][111,112,113,114,115,116]. Miller et al. 3D printed a 1 mm diameter of vascular construct with generation of endothelial cell-line lumen but lack of perfusion to the constructs, thus, having very limited applications
[83][111]. Kolesky and colleagues advanced the application to perfused channels in a 3D printed construct with human mesenchymal stem cells and fibroblasts embedded in an extracellular matrix
[84][112]. They were able to inject the endothelial cells into the 3D printed channels and maintained perfusion for more than six weeks. Two research groups by Skylar-Scott and Brandenberg et al. used high-resolution laser methods to generate microvascularized constructs with a diameter of 20–50 μm simulating capillaries
[85][86][113,114]. However, there is a strong demand on the use of multiplexing printheads since it requires very high resolution and fast printing to print this kind of scale scaffold. Jang et al. demonstrated the promising results of 3D printed complex vascular constructs with functional structures
[87][115]. The 3D printed patch had 8 mm and 0.5 mm for diameter and height, respectively. In vivo animal testing, the developed stem cells improved cardiac functions, reduced cardiac fibrosis and scar formation, thus showing benefits in cardiac repair. Redd et al. presented the similar findings of developing 3D printed perfused microvascular constructs with implanted in the infarcted rat models
[88][116]. The perfusable microvascular grafts as analysed by optical microangiography imaging showed improved vascular remodelling and enhanced coronary perfusion. These results reveal the promise and opportunity for cardiac tissue engineering combined with 3D bioprinting.
Hynes et al. further extended the application of bioprinting to understand the dynamics of circulating tumour cells (CTC) within the vascular beds
[89][117]. They used 3D bioprinting technology to develop living models of the human vasculature channels that are responsive to mechanical stress enabling analysis of biological and physical factors in vitro situation. The biomaterial was planted with human brain microvasculature endothelial cells and were then perfused to generate vascular geometry structures simulating normal tissues with cell growth and formation. CTC cell lines of a metastatic mammary gland carcinoma were chosen to ensure metastatic vascular attachment. Computational fluid modelling was performed to analyse hemodynamic changes such as wall shear stress. Results showed the significant mechanical changes in relation to vessel distensibility with presence of endothelial cells. Particle image velocity (PIV) was used to analyse flow behaviour difference between acellular and endothelialized vessels in comparison with computational simulations. There was a good agreement between predicted and experimentally determined flow patterns for these two vessels. PIV observed the flow partitioning of CTC cells toward the centre of the vessel. This study offers a unique experimental design using a combination of different novel approaches including 3D bioprinting, bioengineering and computation for studying the biophysics of endothelial cell behaviour of CTC during metastasis.